Global Small Molecule Drug CDMO Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 122

Published Date: 14 Mar 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.

According to our (Global Info Research) latest study, the global Small Molecule Drug CDMO Services market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Small Molecule Drug CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Small Molecule Drug CDMO Services market size and forecasts, in consumption value ($ Million), 2019-2030
Global Small Molecule Drug CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Small Molecule Drug CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Small Molecule Drug CDMO Services market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Small Molecule Drug CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Small Molecule Drug CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide, Bachem, Merck, Asymchem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Small Molecule Drug CDMO Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Small Molecule Drug CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Preparation
    Chemical API

Market segment by Application
    Clinical Treatment
    Medical Research
    Commercial Production

Market segment by players, this report covers
    Gliead
    Boehringer Ingelheim
    Vertex
    Mirati Therapeutics
    AMPAC
    Pfizer
    Polypeptide
    Bachem
    Merck
    Asymchem
    Thermo Fisher Scientific
    Zhejiang Jiuzhou Pharmaceutical
    Porton Fine Chemicals
    Lonza Group
    JOINN Biologics
    Zhejiang Langhua Pharmaceutical
    Kingchem (Liaoning) Life Science

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Molecule Drug CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Molecule Drug CDMO Services, with revenue, gross margin, and global market share of Small Molecule Drug CDMO Services from 2019 to 2024.
Chapter 3, the Small Molecule Drug CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Small Molecule Drug CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug CDMO Services.
Chapter 13, to describe Small Molecule Drug CDMO Services research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Small Molecule Drug CDMO Services by Type
        1.3.1 Overview: Global Small Molecule Drug CDMO Services Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Small Molecule Drug CDMO Services Consumption Value Market Share by Type in 2023
        1.3.3 Preparation
        1.3.4 Chemical API
    1.4 Global Small Molecule Drug CDMO Services Market by Application
        1.4.1 Overview: Global Small Molecule Drug CDMO Services Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Clinical Treatment
        1.4.3 Medical Research
        1.4.4 Commercial Production
    1.5 Global Small Molecule Drug CDMO Services Market Size & Forecast
    1.6 Global Small Molecule Drug CDMO Services Market Size and Forecast by Region
        1.6.1 Global Small Molecule Drug CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Small Molecule Drug CDMO Services Market Size by Region, (2019-2030)
        1.6.3 North America Small Molecule Drug CDMO Services Market Size and Prospect (2019-2030)
        1.6.4 Europe Small Molecule Drug CDMO Services Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Small Molecule Drug CDMO Services Market Size and Prospect (2019-2030)
        1.6.6 South America Small Molecule Drug CDMO Services Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Small Molecule Drug CDMO Services Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Gliead
        2.1.1 Gliead Details
        2.1.2 Gliead Major Business
        2.1.3 Gliead Small Molecule Drug CDMO Services Product and Solutions
        2.1.4 Gliead Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Gliead Recent Developments and Future Plans
    2.2 Boehringer Ingelheim
        2.2.1 Boehringer Ingelheim Details
        2.2.2 Boehringer Ingelheim Major Business
        2.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Product and Solutions
        2.2.4 Boehringer Ingelheim Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.3 Vertex
        2.3.1 Vertex Details
        2.3.2 Vertex Major Business
        2.3.3 Vertex Small Molecule Drug CDMO Services Product and Solutions
        2.3.4 Vertex Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Vertex Recent Developments and Future Plans
    2.4 Mirati Therapeutics
        2.4.1 Mirati Therapeutics Details
        2.4.2 Mirati Therapeutics Major Business
        2.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Product and Solutions
        2.4.4 Mirati Therapeutics Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Mirati Therapeutics Recent Developments and Future Plans
    2.5 AMPAC
        2.5.1 AMPAC Details
        2.5.2 AMPAC Major Business
        2.5.3 AMPAC Small Molecule Drug CDMO Services Product and Solutions
        2.5.4 AMPAC Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 AMPAC Recent Developments and Future Plans
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Small Molecule Drug CDMO Services Product and Solutions
        2.6.4 Pfizer Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Pfizer Recent Developments and Future Plans
    2.7 Polypeptide
        2.7.1 Polypeptide Details
        2.7.2 Polypeptide Major Business
        2.7.3 Polypeptide Small Molecule Drug CDMO Services Product and Solutions
        2.7.4 Polypeptide Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Polypeptide Recent Developments and Future Plans
    2.8 Bachem
        2.8.1 Bachem Details
        2.8.2 Bachem Major Business
        2.8.3 Bachem Small Molecule Drug CDMO Services Product and Solutions
        2.8.4 Bachem Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Bachem Recent Developments and Future Plans
    2.9 Merck
        2.9.1 Merck Details
        2.9.2 Merck Major Business
        2.9.3 Merck Small Molecule Drug CDMO Services Product and Solutions
        2.9.4 Merck Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Merck Recent Developments and Future Plans
    2.10 Asymchem
        2.10.1 Asymchem Details
        2.10.2 Asymchem Major Business
        2.10.3 Asymchem Small Molecule Drug CDMO Services Product and Solutions
        2.10.4 Asymchem Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Asymchem Recent Developments and Future Plans
    2.11 Thermo Fisher Scientific
        2.11.1 Thermo Fisher Scientific Details
        2.11.2 Thermo Fisher Scientific Major Business
        2.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product and Solutions
        2.11.4 Thermo Fisher Scientific Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.12 Zhejiang Jiuzhou Pharmaceutical
        2.12.1 Zhejiang Jiuzhou Pharmaceutical Details
        2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
        2.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product and Solutions
        2.12.4 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
    2.13 Porton Fine Chemicals
        2.13.1 Porton Fine Chemicals Details
        2.13.2 Porton Fine Chemicals Major Business
        2.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Product and Solutions
        2.13.4 Porton Fine Chemicals Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Porton Fine Chemicals Recent Developments and Future Plans
    2.14 Lonza Group
        2.14.1 Lonza Group Details
        2.14.2 Lonza Group Major Business
        2.14.3 Lonza Group Small Molecule Drug CDMO Services Product and Solutions
        2.14.4 Lonza Group Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Lonza Group Recent Developments and Future Plans
    2.15 JOINN Biologics
        2.15.1 JOINN Biologics Details
        2.15.2 JOINN Biologics Major Business
        2.15.3 JOINN Biologics Small Molecule Drug CDMO Services Product and Solutions
        2.15.4 JOINN Biologics Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 JOINN Biologics Recent Developments and Future Plans
    2.16 Zhejiang Langhua Pharmaceutical
        2.16.1 Zhejiang Langhua Pharmaceutical Details
        2.16.2 Zhejiang Langhua Pharmaceutical Major Business
        2.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product and Solutions
        2.16.4 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Zhejiang Langhua Pharmaceutical Recent Developments and Future Plans
    2.17 Kingchem (Liaoning) Life Science
        2.17.1 Kingchem (Liaoning) Life Science Details
        2.17.2 Kingchem (Liaoning) Life Science Major Business
        2.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product and Solutions
        2.17.4 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Kingchem (Liaoning) Life Science Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Small Molecule Drug CDMO Services Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Small Molecule Drug CDMO Services by Company Revenue
        3.2.2 Top 3 Small Molecule Drug CDMO Services Players Market Share in 2023
        3.2.3 Top 6 Small Molecule Drug CDMO Services Players Market Share in 2023
    3.3 Small Molecule Drug CDMO Services Market: Overall Company Footprint Analysis
        3.3.1 Small Molecule Drug CDMO Services Market: Region Footprint
        3.3.2 Small Molecule Drug CDMO Services Market: Company Product Type Footprint
        3.3.3 Small Molecule Drug CDMO Services Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Small Molecule Drug CDMO Services Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Small Molecule Drug CDMO Services Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2024)
    5.2 Global Small Molecule Drug CDMO Services Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Small Molecule Drug CDMO Services Consumption Value by Type (2019-2030)
    6.2 North America Small Molecule Drug CDMO Services Market Size by Application (2019-2030)
    6.3 North America Small Molecule Drug CDMO Services Market Size by Country
        6.3.1 North America Small Molecule Drug CDMO Services Consumption Value by Country (2019-2030)
        6.3.2 United States Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        6.3.3 Canada Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        6.3.4 Mexico Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Small Molecule Drug CDMO Services Consumption Value by Type (2019-2030)
    7.2 Europe Small Molecule Drug CDMO Services Consumption Value by Application (2019-2030)
    7.3 Europe Small Molecule Drug CDMO Services Market Size by Country
        7.3.1 Europe Small Molecule Drug CDMO Services Consumption Value by Country (2019-2030)
        7.3.2 Germany Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        7.3.3 France Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        7.3.5 Russia Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        7.3.6 Italy Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Region
        8.3.1 Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Region (2019-2030)
        8.3.2 China Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        8.3.3 Japan Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        8.3.4 South Korea Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        8.3.5 India Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        8.3.7 Australia Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Small Molecule Drug CDMO Services Consumption Value by Type (2019-2030)
    9.2 South America Small Molecule Drug CDMO Services Consumption Value by Application (2019-2030)
    9.3 South America Small Molecule Drug CDMO Services Market Size by Country
        9.3.1 South America Small Molecule Drug CDMO Services Consumption Value by Country (2019-2030)
        9.3.2 Brazil Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        9.3.3 Argentina Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Country
        10.3.1 Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Country (2019-2030)
        10.3.2 Turkey Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)
        10.3.4 UAE Small Molecule Drug CDMO Services Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Small Molecule Drug CDMO Services Market Drivers
    11.2 Small Molecule Drug CDMO Services Market Restraints
    11.3 Small Molecule Drug CDMO Services Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Small Molecule Drug CDMO Services Industry Chain
    12.2 Small Molecule Drug CDMO Services Upstream Analysis
    12.3 Small Molecule Drug CDMO Services Midstream Analysis
    12.4 Small Molecule Drug CDMO Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Small Molecule Drug CDMO Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Small Molecule Drug CDMO Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Small Molecule Drug CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Small Molecule Drug CDMO Services Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Gliead Company Information, Head Office, and Major Competitors
 Table 6. Gliead Major Business
 Table 7. Gliead Small Molecule Drug CDMO Services Product and Solutions
 Table 8. Gliead Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Gliead Recent Developments and Future Plans
 Table 10. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
 Table 11. Boehringer Ingelheim Major Business
 Table 12. Boehringer Ingelheim Small Molecule Drug CDMO Services Product and Solutions
 Table 13. Boehringer Ingelheim Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Boehringer Ingelheim Recent Developments and Future Plans
 Table 15. Vertex Company Information, Head Office, and Major Competitors
 Table 16. Vertex Major Business
 Table 17. Vertex Small Molecule Drug CDMO Services Product and Solutions
 Table 18. Vertex Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Mirati Therapeutics Company Information, Head Office, and Major Competitors
 Table 20. Mirati Therapeutics Major Business
 Table 21. Mirati Therapeutics Small Molecule Drug CDMO Services Product and Solutions
 Table 22. Mirati Therapeutics Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Mirati Therapeutics Recent Developments and Future Plans
 Table 24. AMPAC Company Information, Head Office, and Major Competitors
 Table 25. AMPAC Major Business
 Table 26. AMPAC Small Molecule Drug CDMO Services Product and Solutions
 Table 27. AMPAC Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. AMPAC Recent Developments and Future Plans
 Table 29. Pfizer Company Information, Head Office, and Major Competitors
 Table 30. Pfizer Major Business
 Table 31. Pfizer Small Molecule Drug CDMO Services Product and Solutions
 Table 32. Pfizer Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Pfizer Recent Developments and Future Plans
 Table 34. Polypeptide Company Information, Head Office, and Major Competitors
 Table 35. Polypeptide Major Business
 Table 36. Polypeptide Small Molecule Drug CDMO Services Product and Solutions
 Table 37. Polypeptide Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Polypeptide Recent Developments and Future Plans
 Table 39. Bachem Company Information, Head Office, and Major Competitors
 Table 40. Bachem Major Business
 Table 41. Bachem Small Molecule Drug CDMO Services Product and Solutions
 Table 42. Bachem Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. Bachem Recent Developments and Future Plans
 Table 44. Merck Company Information, Head Office, and Major Competitors
 Table 45. Merck Major Business
 Table 46. Merck Small Molecule Drug CDMO Services Product and Solutions
 Table 47. Merck Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Merck Recent Developments and Future Plans
 Table 49. Asymchem Company Information, Head Office, and Major Competitors
 Table 50. Asymchem Major Business
 Table 51. Asymchem Small Molecule Drug CDMO Services Product and Solutions
 Table 52. Asymchem Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. Asymchem Recent Developments and Future Plans
 Table 54. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
 Table 55. Thermo Fisher Scientific Major Business
 Table 56. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product and Solutions
 Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Thermo Fisher Scientific Recent Developments and Future Plans
 Table 59. Zhejiang Jiuzhou Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 60. Zhejiang Jiuzhou Pharmaceutical Major Business
 Table 61. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product and Solutions
 Table 62. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
 Table 64. Porton Fine Chemicals Company Information, Head Office, and Major Competitors
 Table 65. Porton Fine Chemicals Major Business
 Table 66. Porton Fine Chemicals Small Molecule Drug CDMO Services Product and Solutions
 Table 67. Porton Fine Chemicals Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. Porton Fine Chemicals Recent Developments and Future Plans
 Table 69. Lonza Group Company Information, Head Office, and Major Competitors
 Table 70. Lonza Group Major Business
 Table 71. Lonza Group Small Molecule Drug CDMO Services Product and Solutions
 Table 72. Lonza Group Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 73. Lonza Group Recent Developments and Future Plans
 Table 74. JOINN Biologics Company Information, Head Office, and Major Competitors
 Table 75. JOINN Biologics Major Business
 Table 76. JOINN Biologics Small Molecule Drug CDMO Services Product and Solutions
 Table 77. JOINN Biologics Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 78. JOINN Biologics Recent Developments and Future Plans
 Table 79. Zhejiang Langhua Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 80. Zhejiang Langhua Pharmaceutical Major Business
 Table 81. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product and Solutions
 Table 82. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Zhejiang Langhua Pharmaceutical Recent Developments and Future Plans
 Table 84. Kingchem (Liaoning) Life Science Company Information, Head Office, and Major Competitors
 Table 85. Kingchem (Liaoning) Life Science Major Business
 Table 86. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product and Solutions
 Table 87. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 88. Kingchem (Liaoning) Life Science Recent Developments and Future Plans
 Table 89. Global Small Molecule Drug CDMO Services Revenue (USD Million) by Players (2019-2024)
 Table 90. Global Small Molecule Drug CDMO Services Revenue Share by Players (2019-2024)
 Table 91. Breakdown of Small Molecule Drug CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 92. Market Position of Players in Small Molecule Drug CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 93. Head Office of Key Small Molecule Drug CDMO Services Players
 Table 94. Small Molecule Drug CDMO Services Market: Company Product Type Footprint
 Table 95. Small Molecule Drug CDMO Services Market: Company Product Application Footprint
 Table 96. Small Molecule Drug CDMO Services New Market Entrants and Barriers to Market Entry
 Table 97. Small Molecule Drug CDMO Services Mergers, Acquisition, Agreements, and Collaborations
 Table 98. Global Small Molecule Drug CDMO Services Consumption Value (USD Million) by Type (2019-2024)
 Table 99. Global Small Molecule Drug CDMO Services Consumption Value Share by Type (2019-2024)
 Table 100. Global Small Molecule Drug CDMO Services Consumption Value Forecast by Type (2025-2030)
 Table 101. Global Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024)
 Table 102. Global Small Molecule Drug CDMO Services Consumption Value Forecast by Application (2025-2030)
 Table 103. North America Small Molecule Drug CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 104. North America Small Molecule Drug CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 105. North America Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 106. North America Small Molecule Drug CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 107. North America Small Molecule Drug CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 108. North America Small Molecule Drug CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 109. Europe Small Molecule Drug CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 110. Europe Small Molecule Drug CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 111. Europe Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 112. Europe Small Molecule Drug CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 113. Europe Small Molecule Drug CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 114. Europe Small Molecule Drug CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 115. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 116. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 117. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 118. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 119. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Region (2019-2024) & (USD Million)
 Table 120. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value by Region (2025-2030) & (USD Million)
 Table 121. South America Small Molecule Drug CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 122. South America Small Molecule Drug CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 123. South America Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 124. South America Small Molecule Drug CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 125. South America Small Molecule Drug CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 126. South America Small Molecule Drug CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 127. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Type (2019-2024) & (USD Million)
 Table 128. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Type (2025-2030) & (USD Million)
 Table 129. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Application (2019-2024) & (USD Million)
 Table 130. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Application (2025-2030) & (USD Million)
 Table 131. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Country (2019-2024) & (USD Million)
 Table 132. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value by Country (2025-2030) & (USD Million)
 Table 133. Global Key Players of Small Molecule Drug CDMO Services Upstream (Raw Materials)
 Table 134. Global Small Molecule Drug CDMO Services Typical Customers


List of Figures
 Figure 1. Small Molecule Drug CDMO Services Picture
 Figure 2. Global Small Molecule Drug CDMO Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Small Molecule Drug CDMO Services Consumption Value Market Share by Type in 2023
 Figure 4. Preparation
 Figure 5. Chemical API
 Figure 6. Global Small Molecule Drug CDMO Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Small Molecule Drug CDMO Services Consumption Value Market Share by Application in 2023
 Figure 8. Clinical Treatment Picture
 Figure 9. Medical Research Picture
 Figure 10. Commercial Production Picture
 Figure 11. Global Small Molecule Drug CDMO Services Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Small Molecule Drug CDMO Services Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Market Small Molecule Drug CDMO Services Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 14. Global Small Molecule Drug CDMO Services Consumption Value Market Share by Region (2019-2030)
 Figure 15. Global Small Molecule Drug CDMO Services Consumption Value Market Share by Region in 2023
 Figure 16. North America Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 17. Europe Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 18. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 19. South America Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 20. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 21. Company Three Recent Developments and Future Plans
 Figure 22. Global Small Molecule Drug CDMO Services Revenue Share by Players in 2023
 Figure 23. Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 24. Market Share of Small Molecule Drug CDMO Services by Player Revenue in 2023
 Figure 25. Top 3 Small Molecule Drug CDMO Services Players Market Share in 2023
 Figure 26. Top 6 Small Molecule Drug CDMO Services Players Market Share in 2023
 Figure 27. Global Small Molecule Drug CDMO Services Consumption Value Share by Type (2019-2024)
 Figure 28. Global Small Molecule Drug CDMO Services Market Share Forecast by Type (2025-2030)
 Figure 29. Global Small Molecule Drug CDMO Services Consumption Value Share by Application (2019-2024)
 Figure 30. Global Small Molecule Drug CDMO Services Market Share Forecast by Application (2025-2030)
 Figure 31. North America Small Molecule Drug CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 32. North America Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 33. North America Small Molecule Drug CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 34. United States Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 35. Canada Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 36. Mexico Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 37. Europe Small Molecule Drug CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 38. Europe Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 39. Europe Small Molecule Drug CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 40. Germany Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 41. France Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 42. United Kingdom Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 43. Russia Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 44. Italy Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 45. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 46. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 47. Asia-Pacific Small Molecule Drug CDMO Services Consumption Value Market Share by Region (2019-2030)
 Figure 48. China Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 49. Japan Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 50. South Korea Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 51. India Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 52. Southeast Asia Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 53. Australia Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 54. South America Small Molecule Drug CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 55. South America Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 56. South America Small Molecule Drug CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 57. Brazil Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 58. Argentina Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 59. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value Market Share by Type (2019-2030)
 Figure 60. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value Market Share by Application (2019-2030)
 Figure 61. Middle East & Africa Small Molecule Drug CDMO Services Consumption Value Market Share by Country (2019-2030)
 Figure 62. Turkey Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 63. Saudi Arabia Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 64. UAE Small Molecule Drug CDMO Services Consumption Value (2019-2030) & (USD Million)
 Figure 65. Small Molecule Drug CDMO Services Market Drivers
 Figure 66. Small Molecule Drug CDMO Services Market Restraints
 Figure 67. Small Molecule Drug CDMO Services Market Trends
 Figure 68. Porters Five Forces Analysis
 Figure 69. Small Molecule Drug CDMO Services Industrial Chain
 Figure 70. Methodology
 Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science

Product Tags

Small Molecule Drug CDMO Services

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>